北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China-Study Design and Baseline Characteristics
作者: Ji, Linong1,2; Zhang, Puhong2; Weng, Jianping3; Lu, Juming4; Guo, Xiaohui1; Jia, Weiping5; Yang, Wenying6; Zou, Dajin7; Zhou, Zhiguang8; Pan, Changyu9; Gao, Yan1; Li, Xian2; Zhu, Dongshan2; Li, Ying2; Wu, Yangfeng2; Garg, Satish K.10
刊名: DIABETES TECHNOLOGY & THERAPEUTICS
发表日期: 2015-10-01
DOI: 10.1089/dia.2015.0054
卷: 17, 期:10, 页:735-744
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Endocrinology & Metabolism
研究领域[WOS]: Endocrinology & Metabolism
关键词[WOS]: GLYCEMIC CONTROL ; PRIMARY-CARE ; CLINICAL-PRACTICE ; GLUCOSE CONTROL ; PREVALENCE ; THERAPY ; DETEMIR ; ASSOCIATION ; MANAGEMENT ; RESISTANCE
英文摘要:

Background: Efficacy of basal insulin (BI) has been well studied by randomized controlled trials, but the impact of BI on glycemic control in the real world has not been well documented. The Observational Registry for BI Treatment (ORBIT) study is designed to evaluate the real-life outcomes of BI in China.

Materials and Methods: Participants with type 2 diabetes (n=19,894), from December 2011 to June 2013, inadequately controlled on oral hypoglycemic agents (OHAs) were initiated on BI treatment from 209 hospitals in all the eight regions in Mainland China. Data for each patient on use of OHAs and insulin (type and dose), glycemic control, hypoglycemic episodes, body weight, quality of life, and costs were collected at baseline and 3 and 6 months.

Results: For the 18,995 participants who were eligible for baseline analysis, mean +/- SD age was 55.4 +/- 10.4 years, with 52.5% males. The mean duration of diabetes was 6.4 +/- 5.3 years and was positively associated with the economic level of eight regions. Before initiation of BI, patients had a mean hemoglobin A1c level of 9.6 +/- 2.0% with a fasting plasma glucose level of 11.7 +/- 4.0 mmol/L. Of the patients, 35.5% had some diabetes complications. Metformin, sulfonylureas, and alpha-glycosidase inhibitors were the most commonly used OHAs. The proportions of patients using one, two, or more than two OHAs before BI initiation were 48.4%, 42.7%, and 8.9%, respectively.

Conclusions: To the best of our knowledge, the ORBIT study is the largest registry study to evaluate glycemic outcomes and safety of BI in real-world China. Baseline data indicate delays in initiation of BI in the majority of patients with type 2 diabetes in China.

语种: 英语
项目资助者: Sanofi-Aventis (Shanghai, China)
WOS记录号: WOS:000360967700011
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/64557
Appears in Collections:北京大学第二临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
2.Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing 100088, Peoples R China
3.Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China
4.Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
5.Shanghai 6th Hosp, Shanghai, Peoples R China
6.China Japan Friendship Hosp, Beijing, Peoples R China
7.Second Mil Med Univ, Shanghai, Peoples R China
8.Xiangya Second Hosp, Changsha, Hunan, Peoples R China
9.Beijing 301 Mil Gen Hosp, Beijing, Peoples R China
10.Univ Colorado Denver, Barbara Davis Ctr Diabet, Aurora, CO USA

Recommended Citation:
Ji, Linong,Zhang, Puhong,Weng, Jianping,et al. Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China-Study Design and Baseline Characteristics[J]. DIABETES TECHNOLOGY & THERAPEUTICS,2015,17(10):735-744.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Ji, Linong]'s Articles
[Zhang, Puhong]'s Articles
[Weng, Jianping]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Ji, Linong]‘s Articles
[Zhang, Puhong]‘s Articles
[Weng, Jianping]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2018  北京大学医学部 - Feedback
Powered by CSpace